Extract
Tuberculosis (TB) is the world's leading cause of infectious disease-related mortality, apart from COVID-19 presently [1]. Standard TB treatment for drug-susceptible (DS) TB takes 6–9 months and requires daily intake of multiple medications [1]. Notably, proper treatment adherence is essential for successful treatment outcome [1, 2]. To improve adherence, counselling and education are important.
Abstract
Digital adherence technology in combination with therapeutic drug monitoring could aid in supporting adherence and personalising dosing while at the same time supporting patients to carry out TB medication related tasks independently https://bit.ly/3gh1A1c
Footnotes
Conflict of interest: All authors report that smart pill bottles were provided free of charge by Pill Connect/eLucid mHealth, along with grant payments (made to institution) supporting the present work. D.J. Touw reports grants from Chiesi Pharmaceuticals; consulting fees from PureIMS; lecture honoraria from PAO Farmacie; participation on a data safety monitoring board for the FORMAT trial; and participation on an advisory board for Sanquin, outside the submitted work. M.S. Bolhuis reports consulting fees from Pfizer and Kinderformularium, Pediatric formulary Netherlands; lecture honoraria from PAO Farmacie; outside the submitted work. All other authors have nothing else to disclose.
Support statement: This work was supported by Pill Connect/eLucid mHealth. Funding information for this article has been deposited with the Crossref Funder Registry.
- Received August 29, 2022.
- Accepted October 14, 2022.
- Copyright ©The authors 2022. For reproduction rights and permissions contact permissions{at}ersnet.org
LIBRARY USERS
Log in through your institution
Purchase access
